An international field study for the reliability and validity of the EORTC Sexual Health Questionnaire (EORTC SHQ-C22) for assessing sexual health in cancer patients. - EORTC Sexual Health Questionnaire

Medical University Graz0 个研究点目标入组 40 人开始时间: 待定最近更新: 2024年4月23日

试验速览

暂无简介。

•The study sample will be composed of a consecutive series of cancer patients who meet the study eligibility criteria in each participating centre. Study participants will be enrolled in four groups: Group A: Patients undergoing surgery alone Group B: Patients who receive chemotherapy and/or radiotherapy and/or endocrine therapies as first line treatment with curative intention Group C: Patients who receive palliative treatment (any treatment) Group D: Patients with no evidence of disease who have completed treatment for at least 6 months up to 5 years (test-retest) The SHQ-C22 will be used in patients from across all cancer sites and stages. Sampling will be on the basis of gender, age, primary cancer diagnosis and treatment. a) Histological confirmed diagnosis of cancer (primary, recurrent or metastatic disease) b) Any tumour site and stage c) Mentally fit to complete the questionnaires d) Able to understand the language of the questionnaires e) 18 years of age or above f) Patient is willing to give informed written consent

•Patients participating in other QoL studies that might interfere with this study b) Patients who are unable to self-complete the questionnaires

发起方

Medical University Graz